This Article Full Text Full Text (PDF) Supplemental Data Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Google Scholar Articles by Green, C. D. Articles by Olson, L. K. PubMed PubMed Citation Articles by Green, C. D. Articles by Olson, L. K.

Elevated Insulin Secretion from Liver X Receptor-Activated Pancreatic β-Cells Involves Increased de Novo Lipid Synthesis and Triacylglyceride Turnover

Departments of Physiology (L.K.O.) and Biochemistry and Molecular Biology (C.D.G.), Michigan State University, East Lansing, Michigan 48824-3320; and Department of Nutrition and Exercise Sciences (D.B.J.), Oregon State University, Corvallis, Oregon 97331-5109

Address all correspondence and requests for reprints to: Karl Olson, Department of Physiology, Michigan State University, 3176 Biomedical and Physical Science Building, East Lansing, Michigan 48824-3320. E-mail: olsonla{at}msu.edu.

Increased basal and loss of glucose-stimulated insulin secretion (GSIS) are hallmarks of β-cell dysfunction associated with type 2 diabetes. It has been proposed that elevated glucose promotes insulin secretory defects by activating sterol regulatory element binding protein (SREBP)-1c, lipogenic gene expression, and neutral lipid storage. Activation of liver X receptors (LXRs) also activates SREBP-1c and increases lipogenic gene expression and neutral lipid storage but increases basal and GSIS. This study was designed to characterize the changes in de novo fatty acid and triacylglyceride (TAG) synthesis in LXR-activated β-cells and determine how these changes contribute to elevated basal and GSIS. Treatment of INS-1 β-cells with LXR agonist T0901317 and elevated glucose led to markedly increased nuclear localization of SREBP-1, lipogenic gene expression, de novo synthesis of monounsaturated fatty acids and TAG, and basal and GSIS. LXR-activated cells had increased fatty acid oxidation and expression of genes involved in mitochondrial β-oxidation, particularly carnitine palmitoyltransferase-1. Increased basal insulin release from LXR-activated cells coincided with rapid turnover of newly synthesized TAG and required acyl-coenzyme A synthesis and mitochondrial β-oxidation. GSIS from LXR-activated INS-1 cells required influx of extracellular calcium and lipolysis, suggesting production of lipid-signaling molecules from TAG. Inhibition of diacylglyceride (DAG)-binding proteins, but not classic isoforms of protein kinase C, attenuated GSIS from LXR-activated INS-1 cells. In conclusion, LXR activation in β-cells exposed to elevated glucose concentrations increases de novo TAG synthesis; subsequent lipolysis produces free fatty acids and DAG, which are oxidized to increase basal insulin release and activate DAG-binding proteins to enhance GSIS, respectively.